News

In the US and Europe, Mitral Regurgitation (MR) is the most common valvular heart disease.  It is very difficult to grade MR, but it is extremely important because the more severe the MR is, the worse the prognosis for patients. Unfortunately, using echocardiograms and other modalities to grade MR they is very cumbersome, lengthy and inaccurate. …

AI echo at EACVI 2023 – join us in Barcelona to learn more about echo analysis software. Scientific ValidationAmyloidosis – 10 May (9:30 AM), Moderated ePosters 2Automated analysis of echocardiograms can predict prognosis in ATTR cardiomyopathy Adam Ioannou, National Amyloidosis Centre, University College London, Royal Free Hospital Strain – 10 May (11:30 AM), Teatro Scientifico…

AI POCUS – AI Point-of-Care Ultrasound Heart Screening by Novices in The PANES HF Study New Orleans, LA, March 01, 2023 – (PR.com) – Novice laypersons with no prior experience underwent two-weeks training to acquire echo images among individuals with suspected heart failure using point-of-care ultrasound combined with AI-based image analysis, disease detection and reporting from…

Echo analysis software for AI decision support – a YouTube interview describing how machine learning can democratize healthcare with automated AI echo disease detection

AI echo diagnosis support can assist untrained novices in the interpretation of echocardiograms, as discussed in this YouTube interview

AI echo FDA-cleared echo analysis software to process full echo reports with zero clicks in under 2 minutes SINGAPORE – (BUSINESS WIRE) – Us2.ai, a Singapore-based medtech firm backed by IHH Healthcare, Heal Partners and Sequoia India will provide AI software that assists in analyzing research echocardiograms or heart ultrasounds to Brigham and Women’s Hospital’s Cardiac…

7 Incredible Things I Saw at HLTH2022: Las Vegas. What Happened In Vegas Definitely Won’t Stay There

Cardiac Wire Q&A with Us2.ai president Yoran Hummel to discuss fully automated strain analysis using Us2.ai’s echocardiography decision support platform.  Can you share a little bit about yourself and Us2.ai? My name is Yoran Hummel. Based in the Netherlands, I’m one of three Us2.ai co-founders and the current acting president. I’ve had a long career…

AI applications in cardiac ultrasound to make echo accessible discussed in this YouTube interview